UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
IPO Year:
Exchange: NYSE
Website: unitedhealthgroup.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/11/2025 | $312.00 | Outperform → Neutral | Robert W. Baird |
| 5/21/2025 | $270.00 | Hold → Reduce | HSBC Securities |
| 5/19/2025 | $308.00 | Buy → Hold | TD Cowen |
| 5/14/2025 | Strong Buy → Mkt Perform | Raymond James | |
| 5/14/2025 | $350.00 | Buy → Neutral | BofA Securities |
| 4/22/2025 | $490.00 | Buy → Hold | HSBC Securities |
| 4/21/2025 | Buy → Hold | Argus | |
| 1/10/2025 | $595.00 | Hold → Buy | HSBC Securities |
| 1/6/2025 | $625.00 → $610.00 | Buy | Truist |
| 10/17/2024 | Buy → Hold | HSBC Securities |
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)
FWP - UNITEDHEALTH GROUP INC (0000731766) (Subject)
424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
SCHEDULE 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)
DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)
Robert W. Baird downgraded UnitedHealth from Outperform to Neutral and set a new price target of $312.00
HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00
TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00
Raymond James downgraded UnitedHealth from Strong Buy to Mkt Perform
BofA Securities downgraded UnitedHealth from Buy to Neutral and set a new price target of $350.00
HSBC Securities downgraded UnitedHealth from Buy to Hold and set a new price target of $490.00
Argus downgraded UnitedHealth from Buy to Hold
HSBC Securities upgraded UnitedHealth from Hold to Buy and set a new price target of $595.00
Truist reiterated coverage of UnitedHealth with a rating of Buy and set a new price target of $610.00 from $625.00 previously
HSBC Securities downgraded UnitedHealth from Buy to Hold
AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companie
UnitedHealth Group (NYSE:UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected all current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Stephen Hemsley, Michele Hooper, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as the Company's independent registered public accounting firm. Voted against the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. At its regular quarterly meeting, the Boa
UnitedHealth Group (NYSE:UNH) will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through August 12 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by te
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr
Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley. "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company
CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today that Carla Davis has been appointed as an independent member of its Board of Directors, effective May 6, 2025. Davis joins the Board following an impressive 30-year career in home health and hospice, serving most recently as Senior Vice President of Hospice Operations at LHC Group. "We are excited to welcome Carla to CareXM's Board of Directors," said Si Luo, chief executive officer at CareXM. "Carla was one of the first customer leaders I had the privilege of meeting after joining CareXM, and from our first conversation, her unwavering commitment to advancing the pa
Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well
UnitedHealth Group (NYSE:UNH) will release its first quarter 2025 financial results on Thursday, April 17, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through May 1 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technol
Rising prices set by pharmaceutical companies are causing pharmacies across the United States to pay more for many drugs, impacting their ability to maintain high-quality care for patients. Effective immediately and with full implementation by January 2028, Optum Rx will align payment models more closely to the costs pharmacies may face due to manufacturer pricing actions. This change will positively impact Optum Rx non-affiliated network pharmacies, including the more than 24,000 independent, community pharmacies we serve. These cost-based payment models will also provide more consistently affordable experiences for consumers. With this change, Optum Rx is addressing a legacy, industry-w
Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal to more than 10% of overall pharmacy prior authorizations. "Optum Rx is taking meaningful steps to simplify patient experiences and increase access to critical medications," said Patrick Conway, M.D., chief executive officer, Optum Rx "These changes mean easier access to medications for consumers, less work for pharmacists and physicians, and a simplified system focused on clinical quality." The initiative focuses first on approximately 80 drugs, and Optum Rx will work with physicians and pha
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)